Cadila Of India To Expand On Being First With H1N1 Flu Vaccine
This article was originally published in PharmAsia News
Executive Summary
India's Cadila Healthcare plans to take advantage of being granted the nation's first approval for an H1N1 flu vaccine and expand into other areas
|
India's Cadila Healthcare plans to take advantage of being granted the nation's first approval for an H1N1 flu vaccine and expand into other areas. Zydus Cadila has determined its priority is to develop a rabies vaccine, a drug that has great demand, but is not yet available. The company is geared to continue investing in its vaccine business over the next three to four years, with a focus on funding production, pre-clinical and clinical development of its products. (Click here for more) "Cadila Healthcare Seeks To Expand Vaccine Business" - Livemint (India) (5/23/10) |